On August 31, 2022 2seventy bio, Inc. (Nasdaq: TSVT), a leading immuno-oncology cell therapy company, reported that members of the management team will participate in the following upcoming investor conferences (Press release, 2seventy bio, AUG 31, 2022, View Source [SID1234618802]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

17th Annual Citi BioPharma Conference, "Cell Therapy Part 1" panel on Wednesday, September 7, 2022 at 9:40am ET in Boston, MA
2022 Morgan Stanley Global Healthcare Conference, fireside chat on Wednesday, September 14, 2022 at 11:45am ET in New York, NY
Live webcasts will be available via the Investors and Media section of 2seventy bio’s website at View Source A replay will be archived on 2seventy bio’s site for 30 days following the event.